Pharmaceutical manufacturer Adcock Ingram’s said on Tuesday that headline earnings per share (HEPS) for the six months to end-December will be at least 27%, or 40c, higher than the previous period.At 9.45am the company’s share price was up 1.68% at R61, having gained 4.54% so far in 2018.Earnings per share (EPS) would rise by at least 12%, with this lower figure attributable to non-trading capital profits the company received in October 2016. This related to Adcock’s disposal of its business interests in India.A more refined range of expected HEPS and EPS would be published in due course, the group said in a trading statement.Adcock, whose major market by turnover remains in SA, had reported HEPS of 148.6c for the half year to end-December 2016, declaring a cash dividend of 63c.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now